- Business
- Hainan Huluwa Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals primarily focused on children's medicines for respiratory and digestive systems, anti-infectives, nutritional supplements, health foods, special medical foods, and medical devices. Its core products include Xiaoer Feire Kechuan Granules, Changyanning Granules and Capsules, Keke Tablets, pediatric lung heat cough asthma granules, bromhexine hydrochloride for injection, compound Banlangen granules, omeprazole enteric-coated capsules, omeprazole sodium for injection, cefixime dispersible tablets, compound dendrobium granules, compound fresh dendrobium granules, compound cold cough tablets, compound lysine granules, compound anti-lung cream, valsartan amlodipine tablets, oseltamivir phosphate capsules, and ibuprofen suspension; the company also offers gynecological, cardiovascular, and neurological medicines under the Huluwa brand. Founded in 2005 and headquartered in Haikou, Hainan Province, China, at No. 30 Andu 1st Road, Xiuying District, the company primarily serves the domestic Chinese market with approximately 2,100 employees. Recent developments include entering an agreement to acquire a 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd., obtaining registration certificates for Cefprozil for Oral Suspension and amendments for Cefotaxime Sodium for Injection, and pursuing R&D investments in new drug formulations alongside planned expansions into Southeast Asia through distributor partnerships.